These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 21585710)

  • 1. Assessing protein kinase selectivity with molecular dynamics and mm-pbsa binding free energy calculations.
    Muzzioli E; Del Rio A; Rastelli G
    Chem Biol Drug Des; 2011 Aug; 78(2):252-9. PubMed ID: 21585710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can MM-PBSA calculations predict the specificities of protein kinase inhibitors?
    Page CS; Bates PA
    J Comput Chem; 2006 Dec; 27(16):1990-2007. PubMed ID: 17036304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of an automated procedure for the prediction of relative free energies of binding on a set of aldose reductase inhibitors.
    Ferrari AM; Degliesposti G; Sgobba M; Rastelli G
    Bioorg Med Chem; 2007 Dec; 15(24):7865-77. PubMed ID: 17870536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Explicitly solvated ligand contribution to continuum solvation models for binding free energies: selectivity of theophylline binding to an RNA aptamer.
    Freedman H; Huynh LP; Le L; Cheatham TE; Tuszynski JA; Truong TN
    J Phys Chem B; 2010 Feb; 114(6):2227-37. PubMed ID: 20099932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular insight into pseudolysin inhibition using the MM-PBSA and LIE methods.
    Adekoya OA; Willassen NP; Sylte I
    J Struct Biol; 2006 Feb; 153(2):129-44. PubMed ID: 16376106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of the mechanism of selectivity of protein tyrosine phosphatase 1B (PTP1B) bidentate inhibitors using molecular dynamics simulations and free energy calculations.
    Fang L; Zhang H; Cui W; Ji M
    J Chem Inf Model; 2008 Oct; 48(10):2030-41. PubMed ID: 18831546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding free energies and free energy components from molecular dynamics and Poisson-Boltzmann calculations. Application to amino acid recognition by aspartyl-tRNA synthetase.
    Archontis G; Simonson T; Karplus M
    J Mol Biol; 2001 Feb; 306(2):307-27. PubMed ID: 11237602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure modeling, ligand binding, and binding affinity calculation (LR-MM-PBSA) of human heparanase for inhibition and drug design.
    Zhou Z; Bates M; Madura JD
    Proteins; 2006 Nov; 65(3):580-92. PubMed ID: 16972282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha7 nicotinic acetylcholine receptor agonists: prediction of their binding affinity through a molecular mechanics Poisson-Boltzmann surface area approach.
    Grazioso G; Cavalli A; De Amici M; Recanatini M; De Micheli C
    J Comput Chem; 2008 Nov; 29(15):2593-602. PubMed ID: 18478580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular dynamics investigation on a series of HIV protease inhibitors: assessing the performance of MM-PBSA and MM-GBSA approaches.
    Srivastava HK; Sastry GN
    J Chem Inf Model; 2012 Nov; 52(11):3088-98. PubMed ID: 23121465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping the binding site of a large set of quinazoline type EGF-R inhibitors using molecular field analyses and molecular docking studies.
    Hou T; Zhu L; Chen L; Xu X
    J Chem Inf Comput Sci; 2003; 43(1):273-87. PubMed ID: 12546563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analyzing the robustness of the MM/PBSA free energy calculation method: application to DNA conformational transitions.
    Brice AR; Dominy BN
    J Comput Chem; 2011 May; 32(7):1431-40. PubMed ID: 21284003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probing interaction requirements in PTP1B inhibitors: a comparative molecular dynamics study.
    Kumar R; Shinde RN; Ajay D; Sobhia ME
    J Chem Inf Model; 2010 Jun; 50(6):1147-58. PubMed ID: 20455572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity prediction and structural insights of extracellular signal-regulated kinase 2 inhibitors with molecular dynamics simulations.
    Del Rio A; Baldi BF; Rastelli G
    Chem Biol Drug Des; 2009 Dec; 74(6):630-5. PubMed ID: 19843074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An MM/3D-RISM approach for ligand binding affinities.
    Genheden S; Luchko T; Gusarov S; Kovalenko A; Ryde U
    J Phys Chem B; 2010 Jul; 114(25):8505-16. PubMed ID: 20524650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A challenging system: free energy prediction for factor Xa.
    Wallnoefer HG; Liedl KR; Fox T
    J Comput Chem; 2011 Jun; 32(8):1743-52. PubMed ID: 21374633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic and binding effects in peptide substrate selectivity of matrix metalloproteinase-2: Molecular dynamics and QM/MM calculations.
    Díaz N; Suárez D; Suárez E
    Proteins; 2010 Jan; 78(1):1-11. PubMed ID: 19585658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimum sequence requirements for selective RNA-ligand binding: a molecular mechanics algorithm using molecular dynamics and free-energy techniques.
    Anderson PC; Mecozzi S
    J Comput Chem; 2006 Nov; 27(14):1631-40. PubMed ID: 16900493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the molecular mechanics poisson-boltzmann surface area free energy method using a congeneric series of ligands to p38 MAP kinase.
    Pearlman DA
    J Med Chem; 2005 Dec; 48(24):7796-807. PubMed ID: 16302819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Including explicit water molecules as part of the protein structure in MM/PBSA calculations.
    Zhu YL; Beroza P; Artis DR
    J Chem Inf Model; 2014 Feb; 54(2):462-9. PubMed ID: 24432790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.